Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection?
Tóm tắt
In recent times, increasing reports of exit site infections (ESI) in peritoneal dialysis (PD) patients related to environmentally acquired atypical organisms, such as nontuberculous mycobacterium (NTM), have been reported in the literature. Among these NTM, Mycobacterium abscessus (M. abscessus) is unique and is associated with high morbidity and treatment failure rates. The international society of PD guidelines suggests individualizing therapeutic options for NTM-related ESI. Moreover, the guidelines encourage simultaneous catheter removal and reinsertion (SCRR) in isolated ESI, not responding to antimicrobial therapy to avoid PD interruptions. Physicians should be aware of the limitations of such approaches as delay in appropriate PD catheter intervention can be fraught with complications in patients with M. abscessus ESI. We report an M. abscessus ESI in a PD patient who underwent SCRR in conjunction with targeted antimicrobial therapy, and developed M. abscessus peritonitis requiring PD catheter removal and conversion to hemodialysis. The patient also developed ESI at the new exit site long after the PD catheter was removed, requiring prolonged antimicrobial therapy. Our case, taken together with available published case reports, highlights the futility of the SCRR approach towards the M. abscessus ESI and makes the cases for early PD catheter removal in these patients.
Tài liệu tham khảo
Lan PG, Clayton PA, Johnson DW, Mcdonald SP, Borlace M, Badve SV, et al. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure. Perit Dial Int. 2016;36(6):623–30. https://doi.org/10.3747/pdi.2015.00218.
Shen JI, Mitani AA, Saxena AB, Goldstein BA, Winkelmayer WC. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013;33(2):155–66. https://doi.org/10.3747/pdi.2011.00233.
Jaar BG, Plantinga LC, Crews DC, Fink NE, Hebah N, Coresh J, et al. Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol. 2009;10(1):3. https://doi.org/10.1186/1471-2369-10-3.
Crabtree JH, Siddiqi RA. Simultaneous catheter replacement for infectious and mechanical complications without interruption of peritoneal dialysis. Perit Dial Int. 2016;36(2):182–7. https://doi.org/10.3747/pdi.2014.00313.
Szeto C-C, Li PK-T, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141–54. https://doi.org/10.3747/pdi.2016.00120.
Chamarthi G, Kamboj M, Archibald LK, Shukla AM. Mycobacterium abscessus exit-site infection in peritoneal dialysis patients: should we ever aim to salvage the catheter? CEN Case Rep. 2020. https://doi.org/10.1007/s13730-020-00506-5.
Sloan CE, Coffman CJ, Sanders LL, Maciejewski ML, Lee S-YD, Hirth RA, et al. Trends in peritoneal dialysis use in the United States after medicare payment reform. Clin J Am Soc Nephrol. 2019;14(12):1763–72. https://doi.org/10.2215/cjn.05910519.
Flanagin EP, Chivate Y, Weiner DE. Home dialysis in the United States: a roadmap for increasing peritoneal dialysis utilization. Am J Kidney Dis. 2020;75(3):413–6. https://doi.org/10.1053/j.ajkd.2019.10.013.
Lo MW, Mak SK, Wong YY, Lo KC, Chan SF, Tong GM, et al. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int. 2013;33(3):267–72. https://doi.org/10.3747/pdi.2011.00184.
Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int. 2012;32(5):525–30. https://doi.org/10.3747/pdi.2011.00183.
Renaud CJ, Subramanian S, Tambyah PA, Lee EJ. The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: A case series and literature review. Nephrology (Carlton). 2011;16(2):174–9. https://doi.org/10.1111/j.1440-1797.2010.01370.x.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. https://doi.org/10.1164/rccm.200604-571ST.
Jo A, Ishibashi Y, Hirohama D, Takara Y, Kume H, Fujita T. Early surgical intervention may prevent peritonitis in cases with Tenckhoff catheter infection by nontuberculous mycobacterium. Perit Dial Int. 2012;32(2):227–9. https://doi.org/10.3747/pdi.2011.00080.
Johansen MD, Herrmann J-L, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol. 2020;18(7):392–407. https://doi.org/10.1038/s41579-020-0331-1.
Lee M-R, Sheng W-H, Hung C-C, Yu C-J, Lee L-N, Hsueh P-R. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015. https://doi.org/10.3201/2109.141634.
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508. https://doi.org/10.3747/pdi.2016.00078.
Mooren V, Bleeker MWP, van Ingen J, Hermans MHA, Wever PC. Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient. IDCases. 2017;9:6–7. https://doi.org/10.1016/j.idcr.2017.05.001.
Kameyama H, Mori Y, Kimura T, Sugishita C, Adachi T, Sonomura K, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007;11(6):449–51. https://doi.org/10.1111/j.1744-9987.2007.00526.x.
Yoshimura R, Kawanishi M, Fujii S, Yamauchi A, Takase K, Yoshikane K, et al. Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report. BMC Nephrol. 2018;19(1):341. https://doi.org/10.1186/s12882-018-1148-2.
Ono M, Arnaoutakis GJ, Fine DM, Brady K, Easley RB, Zheng Y, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury*. Crit Care Med. 2013;41(2):464–71. https://doi.org/10.1097/ccm.0b013e31826ab3a1.
Meng C, Beco A, Oliveira A, Pereira L, Pestana M. Peritoneal dialysis cuff-shaving-a salvage therapy for refractory exit-site infections. Perit Dial Int. 2019;39(3):276–81. https://doi.org/10.3747/pdi.2018.00193.
Maeda Y, Uno T, Yoshida A, Takahashi A, Inaba N, Shiigai T. Nontuberculous mycobacterial peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. J Rural Med. 2009;4(2):75–9. https://doi.org/10.2185/jrm.4.75.
Marzuk SM, Rohit A, Nagarajan P, Nzana V, Katuraga VM, Parthasarathy R, et al. An unusual case of unresolving tunnel infection in a patient on continuous ambulatory peritoneal dialysis. Indian J Med Microbiol. 2018;36(4):600–2. https://doi.org/10.4103/ijmm.IJMM_18_425.
Tsai S-F. Catheter related infection due to Mycobacterium abscessus in a patient under peritoneal dialysis. Ther Apher Dial. 2013;17(3):349–50. https://doi.org/10.1111/1744-9987.12005.
Hibi A, Kasugai T, Kamiya K, Ito C, Kominato S, Mizuguchi K, et al. Peritoneal dialysis-associated catheter infection caused by Mycobacterium abscessus in an elderly patient who was successfully treated with catheter removal. CEN Case Rep. 2017;6(2):175–9. https://doi.org/10.1007/s13730-017-0270-5.
Ellis EN, Schutze GE, Wheeler JG. Nontuberculous mycobacterial exit-site infection and abscess in a peritoneal dialysis patient. A case report and review of the literature. Pediatr Nephrol. 2005;20(7):1016–8. https://doi.org/10.1007/s00467-005-1870-4.
Inoue H, Washida N, Morimoto K, Shinozuka K, Kasai T, Uchiyama K, et al. Non-tuberculous mycobacterial infections related to peritoneal dialysis. Perit Dial Int. 2018;38(2):147–9. https://doi.org/10.3747/pdi.2017.00172.